Dark Forest Capital Management’s Intercept Pharmaceuticals, Inc. ICPT Stock Holding History

Dark Forest Capital Management’s Portfolio ICPT Stock Details ICPT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-10,193	Closed	-$113K	–	1373
2023 Q2	$113K	Buy	10,193 +8,130	+394%	+$113K	0.01%	974
2023 Q1	$27.7K	Buy	+2,063	New	+$35.7K	0.01%	930
2022 Q3	–	Sell	-19	Closed	–	–	1529
2022 Q2	$0	Buy	+19	New	+$304	﹤0.01%	1503
2022 Q1	–	Sell	-3	Closed	–	–	1897
2021 Q4	$0	Sell	3 -132	-98%	-$2.23K	﹤0.01%	1864
2021 Q3	$2K	Buy	+135	New	+$2.16K	﹤0.01%	1182

Other funds holding ICPT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Magnetar Financial Evanston, Illinois $9.84B AUM 190.64% 1-Year Est. Return

AAM

Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return

Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

JFG

Jefferies Financial Group New York $14.6B AUM 40.95% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Pictet Asset Management Carouge, Switzerland $94.8B AUM 24.11% 1-Year Est. Return

Dark Forest Capital Management's ICPT Position: Q3 2023 in Review

Dark Forest Capital Management sold out of Intercept Pharmaceuticals, Inc. (ICPT) in Q3 2023, closing a stake of 10,193 shares — an estimated $113K sold.

Dark Forest Capital Management first reported a position in ICPT in Q3 2021 and held it in 5 quarters. The position peaked at $113K in Q2 2023. 146 funds tracked by Wall St. Rank hold ICPT as of Q3 2023.

Dark Forest Capital Management reported no remaining Intercept Pharmaceuticals, Inc. position as of Q3 2023 after selling out during the quarter.
Dark Forest Capital Management sold 10,193 Intercept Pharmaceuticals, Inc. shares in Q3 2023, an estimated $113K.
Dark Forest Capital Management first reported a position in Intercept Pharmaceuticals, Inc. in Q3 2021 and held it in 5 quarters.
Dark Forest Capital Management's Intercept Pharmaceuticals, Inc. position peaked at $113K in Q2 2023.
146 funds tracked by Wall St. Rank held Intercept Pharmaceuticals, Inc. as of Q3 2023.

Based on Dark Forest Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.